EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort

Rodica Pop-Busui iD, Samuel P Rosin, Nicole M Butera iD, Heidi Krause-Steinrauf iD, Hiba Abou Assi, Rajesh K Garg, Silvio E Inzucchi iD, Aimee Katona, Janet B McGill, Sunder Mudaliar, David S Schade iD, Elizabeth R Seaquist iD und 4 weitere

Diabetes Care · 2025

DOI: 10.2337/dc25-1087 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Care, 2025. Verfasst von Rodica Pop-Busui und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health & Science University, Portland, OR. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Diabetic Neuropathies. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To describe the prevalence and incidence of electrocardiogram (ECG) abnormalities and ECG-derived cardiovascular autonomic neuropathy (CAN) in the GRADE cohort of adults with type 2 diabetes (T2D) <10 years. RESEARCH DESIGN AND METHODS Individuals with T2D taking metformin alone were randomly assigned to add insulin glargine, glimepiride, liraglutide, or sitagliptin. Resting ECGs were completed at the baseline, 2-year, and 4-year study visits and analyzed for minor and major abnormalities and CAN assessed with heart rate variability (HRV) in 4,769 participants. Incidence of new major, minor, and any ECG abnormalities and CAN by treatment group was analyzed using logistic repeated-measures models at years 2 and 4 adjusted for baseline risk factors. RESULTS At baseline, participants were a mean age of 57.2 ± 10.0 years, 36.3% were women, mean diabetes duration was 4.3 ± 2.8 years, and mean HbA1c was 7.5 ± 0.5%. Participants with ECG abnormalities at baseline (57.1%) and ECG-derived CAN (52.8%) were older and had more severe cardiovascular risk factors. The incidence of minor and major ECG abnormalities was similar among all treatment groups. However, at year 4, major ECG abnormalities were fewer in the liraglutide versus nonliraglutide groups (9% vs. 13%; P = 0.03). The incidence of CAN did not differ between the liraglutide and nonliraglutide groups across visits (P = 0.42); however, one measure of HRV (SD of normal-to-normal R-R intervals) was higher at year 2 in the liraglutide versus nonliraglutide groups (P = 0.02). CONCLUSIONS ECG abnormalities, including those reflecting CAN, are common in individuals with T2D <10 years and more so in those with certain cardiovascular risk factors. The development of major ECG abnormalities may be lower with liraglutide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hypoglycemic AgentsDiabetic NeuropathiesHumansFemaleMiddle AgedMaleElectrocardiographyLiraglutideMetforminSulfonylurea CompoundsAgedPrevalenceIncidenceSitagliptin PhosphateInsulin GlargineCardiovascular Diseases

Substanzen

Hypoglycemic AgentsLiraglutideMetforminSulfonylurea CompoundsSitagliptin PhosphateglimepirideInsulin Glargine

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health & Science University, Portland, OR.
  • Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
  • The Biostatistics Center, Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, The George Washington University, Rockville, MD.
  • Division of Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, Durham, NC.
  • Department of Medicine, University of Miami, Miami, FL.
  • Section of Endocrinology, Yale School of Medicine, New Haven, CT.

ORCID-Profile: Rodica Pop-Busui, Nicole M Butera, Heidi Krause-Steinrauf, Silvio E Inzucchi, David S Schade, Elizabeth R Seaquist, Elsayed Z Soliman, Jennifer B Green

Förderung

  • NCATS NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • American Diabetes Association
  • NIGMS NIH HHS
  • CDC HHS
  • Centers for Disease Control and Prevention
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Pop-Busui, R., Rosin, S. P., Butera, N. M., Krause-Steinrauf, H., Abou Assi, H., Garg, R. K., Inzucchi, S. E., Katona, A., McGill, J. B., Mudaliar, S., Schade, D. S., Seaquist, E. R., Tiktin, M., Soliman, E. Z., Green, J. B., & GRADE Research Group (2025). Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort. Diabetes Care. https://doi.org/10.2337/dc25-1087

Vancouver

Pop-Busui R, Rosin SP, Butera NM, Krause-Steinrauf H, Abou Assi H, Garg RK, et al. Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort. Diabetes Care. 2025. doi:10.2337/dc25-1087

BibTeX
@article{PopBusui2025,
  author = {Pop-Busui, Rodica and Rosin, Samuel P and Butera, Nicole M and Krause-Steinrauf, Heidi and Abou Assi, Hiba and Garg, Rajesh K and Inzucchi, Silvio E and Katona, Aimee and McGill, Janet B and Mudaliar, Sunder and Schade, David S and Seaquist, Elizabeth R and Tiktin, Margaret and Soliman, Elsayed Z and Green, Jennifer B and GRADE Research Group, GRADE Research Group},
  title = {Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort},
  journal = {Diabetes Care},
  year = {2025},
  doi = {10.2337/dc25-1087}
}
Kostenlos starten →